Investment Summary |
|
---|---|
Date | 2001-01-08 |
Target | Mycotech |
Sector | Chemicals |
Sellers(s) | Davenport Resources |
Deal Type | Trade Sale |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1995 |
Size | Small |
Type | Sector Agnostic |
Davenport Resources is a private equity firm that makes early and expansion stage venture capital investments in technology and energy opportunities. Areas of interest include clean technologies, infrastructure, and renewable power development. In addition to investing in renewable and clean power generation, Davenport also manages private equity funds for investors interested in clean energy and makes direct investments for its own account in the US and Europe. Davenport Resources was formed in 1995 and is based in Greenwich, Connecticut.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Chemicals) | 1 of 1 |
Type (Trade Sale) | 1 of 2 |
State (Montana) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2001) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2004-09-30 |
Demegen
Pittsburgh, Pennsylvania, United States Demegen, Inc. designs unique peptides for attacking cancer, viruses and bacteria. |
Sell | - |